Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Topical Products

Omeza Lidocaine Lavage and Skin Protectant Gel Recalled for Manufacturing Issues

Agency Publication Date: February 4, 2024
Share:
Sign in to monitor this recall

Summary

OMEZA LLC is recalling approximately 5,600 vials of Omeza Lidocaine Lavage pain relief oil and Omeza Skin Protectant Gel due to manufacturing deviations that violate federal safety standards. The recall includes 4,390 vials of the lidocaine pain relief oil (lidocaine) and 1,210 vials of the skin protectant gel. No injuries or adverse events have been reported to date, but the manufacturing issues may compromise product quality.

Risk

Failure to follow good manufacturing practices can lead to products that are unsafe or ineffective for their intended use. While no specific harm has been reported, these manufacturing deviations indicate that the products were not produced under controlled conditions required to ensure consumer safety.

What You Should Do

  1. The recalled products are Omeza Lidocaine Lavage pain relief oil (10*2mL Vials) and Omeza Skin Protectant Gel (10*2mL Vials) sold in packaging containing 10 vials of 2mL each.
  2. Check your product for the following identifiers for Lidocaine Lavage: lots 28622 2-1 (Expiration April 24, 2024), 286222-3 (Expiration January 25, 2024), or 286222-3 (Expiration April 25, 2024).
  3. Check your product for the following identifiers for Skin Protectant Gel: lots 19123 4-1 (Expiration May 11, 2024) or lot 19123.
  4. If you have health concerns regarding the use of these products, contact your healthcare provider or pharmacist.
  5. Return any unused product to the place of purchase for a refund, throw it away, or contact OMEZA LLC for further instructions.
  6. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Omeza Lidocaine Lavage pain relief oil (10*2mL VIALS)
Variants: 10*2mL Vials
Lot Numbers:
28622 2-1 (Exp. 04/24/2024)
286222-3 (Exp. 1/25/2024)
286222-3 (Exp. 04/25/2024)

Recall #: D-0288-2024

Product: Omeza Skin Protectant Gel (10*2mL Vials)
Variants: 10*2mL Vials
Lot Numbers:
19123 4-1 (Exp. 05/11/2024)
19123

Recall #: D-0289-2024

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 93847
Status: Resolved
Manufacturer: OMEZA LLC
Sold By: Distributors
Manufactured In: United States
Units Affected: 2 products (4390 vials; 1210 vials)
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.